ABO blood-group antigens in oral cancer

Journal of Dental Research

Volumn 84, Issue 1, 2005, Pages 21-28

  Dabelsteen, E ^a   Gao, S ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

ABO blood group antigens; Carbohydrate antigens; Oral cancer; Oral precancer

Indexed keywords

GLYCOSYLTRANSFERASE;

ANIMAL; BIOSYNTHESIS; BLOOD; BLOOD GROUP ABO SYSTEM; CELL MOTION; DNA METHYLATION; GENE EXPRESSION REGULATION; GENETICS; HETEROZYGOSITY LOSS; HUMAN; METABOLISM; MOUTH TUMOR; PROMOTER REGION; REVIEW; SQUAMOUS CELL CARCINOMA;

ABO BLOOD-GROUP SYSTEM; ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL MOVEMENT; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOSYLTRANSFERASES; HUMANS; LOSS OF HETEROZYGOSITY; MOUTH NEOPLASMS; PROMOTER REGIONS (GENETICS);

EID: 16644367146     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/154405910508400103     Document Type: Review

References (72)

1. Baylin SB, Herman JG (2000). DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 16:168-174.
2. Bird AP (1986). CpG-rich islands and the function of DNA methylation. Nature 321:209-213.
3. Bird A (2002). DNA methylation patterns and epigenetic memory. Genes Dev 16:6-21.
4. Bruckner K, Perez L, Clausen H, Cohen S (2000). Glycosyltransferase activity of Fringe modulates Notch-Delta interactions. Nature 406:411-415.
5. Bryne M, Thrane PS, Dabelsteen E (1991). Loss of expression of blood group antigen H is associated with cellular invasion and spread of oral squamous cell carcinomas. Cancer 67:613-618.
6. Clausen H, White T, Takio K, Titani K, Stroud M, Holmes E, et al (1990). Isolation to homogeneity and partial characterization of a histo-blood group A defined Fuc alpha 1-2Gal alpha 1-3-N-acetylgalactosaminyltransferase from human lung tissue. J Biol Chem 265:1139-1145.
7. Clausen H, Bennett EP, Grunnet N (1994). Molecular genetics of ABO histo-blood groups. Transfus Clin Biol 1:79-89.
8. Dabelsteen E (1996). Cell surface carbohydrates as prognostic markers in human carcinomas. J Pathol 179:358-369.
9. Dabelsteen E, Fejerskov O (1974). Loss of epithelial blood group antigen-A during wound healing in oral mucous membrane. Acta Pathol Microbiol Scand [A] 82:431-434.
10. Dabelsteen E, Roed-Petersen B, Pindborg JJ (1975). Loss of epithelial blood group antigens A and B in oral premalignant lesions. Acta Pathol Microbiol Scand [A] 83:292-300.
11. Dabelsteen E, Vedtofte P, Hakomori S, Young WW Jr (1983). Accumulation of a blood group antigen precursor in oral premalignant lesions. Cancer Res 43:1451-1454.
12. Dabelsteen E, Mandel U, Clausen H (1991). Cell surface carbohydrates are markers of differentiation in human oral epithelium. Crit Rev Oral Biol Med 2:493-507.
13. Dabelsteen E, Gron B, Mandel U, Mackenzie I (1998). Altered expression of epithelial cell surface glycoconjugates and intermediate filaments at the margins of mucosal wounds. J Invest Dermatol 111:592-597.
14. Ebnet K, Vestweber D (1999). Molecular mechanisms that control leukocyte extravasation: the selecting and the chemokines. Histochem Cell Biol 112:1-23.
15. Esteller M, Corn PG, Baylin SB, Herman JG (2001). A gene hypermethylation profile of human cancer. Cancer Res 61:3225-3229.
16. Fenderson BA, Holmes EH, Fukushi Y, Hakomori S (1986). Coordinate expression of X and Y haptens during murine embryogenesis. Dev Biol 114:12-21.
17. Fukuda M (2002). Roles of mucin-type O-glycans in cell adhesion. Biochim Biophys Acta 1573:394-405.
18. Fukuda M, Hiraoka N, Yeh JC (1999). C-type lectins and sialyl Lewis X oligosaccharides. Versatile roles in cell-cell interaction. J Cell Biol 147:467-470.
19. Fuster MM, Brown JR, Wang L, Esko JD (2003). A disaccharide precursor of sialyl Lewis X inhibits metastatic potential of tumor cells. Cancer Res 63:2775-2781.
20. Gao S, Bennett EP, Reibel J, Chen XC, Christensen ME, Krogdahl A, et al. (2004a). Histo-blood group ABO antigen in oral potentially malignant lesions and squamous cell carcinoma-genotypic and phenotypic characterization. APMIS 112:11-20.
21. Gao S, Worm J, Guldberg P, Eiberg H, Krogdahl A, Liu CJ (2004b). Genetic and epigenetic alterations of the blood group ABO gene in oral squamous cell carcinoma. Int J Cancer 109:230-237.
22. Gao S, Worm J, Guldberg P, Eiberg H, Krogdahl A, Sørensen JA, et al. (2004c). Loss of heterozygosity at 9q33 and hypermethylation of the DBCCR1 gene in oral squamous cell carcinoma. Br J Cancer 91:760-764.
23. Garrigues J, Anderson J, Hellstrom KE, Hellstrom I (1994). Anti-tumor antibody BR96 blocks cell migration and binds to a lysosomal membrane glycoprotein on cell surface microspikes and ruffled membranes. J Cell Biol 125:129-142.
24. Greenwell P (1997). Blood group antigens: molecules seeking a function? Glycoconj J 14:159-173.
25. Habuchi T, Yoshida O, Knowles MA (1997). A novel candidate tumour suppressor locus at 9q32-33 in bladder cancer: localization of the candidate region within a single 840 kb YAC. Hum Mol Genet 6:913-919.
26. Hakomori S (1985). Aberrant glycosylation in cancer cell membranes as focused on glycolipids: overview and perspectives. Cancer Res 45:2405-2414.
27. Hakomori S (1999). Antigen structure and genetic basis of histo-blood groups A, B and O: their changes associated with human cancer. Biochim Biophys Acta 1473:247-266.
28. Hakomori S (2002). Glycosylation defining cancer malignancy: new wine in an old bottle. Proc Natl Acad Sci USA 99:10231-10233.
29. Hakomori S (2003). Structure, organization, and function of glycosphingolipids in membrane. Curr Opin Hematol 10:16-24.
30. Hakomori S, Handa K (2002). Glycosphingolipid-dependent cross-talk between glycosynapses interfacing tumor cells with their host cells: essential basis to define tumor malignancy. FEBS Lett 531:88-92.
31. Hakomori SI, Koscielak J, Bloch KJ, Jeanloz RW (1967). Immunologic relationship between blood group substances and a fucose-containing glycolipid of human adenocarcinoma. J Immunol 98:31-38.
32. Halloran MM, Carley WW, Polverini PJ, Haskell CJ, Phan S, Anderson BJ, et al (2000). Ley/H: an endothelial-selective, cytokine-inducible, angiogenic mediator. J Immunol 164:4868-4877.
33. Hartmann G (1941). Group antigens in human organs (thesis, Copenhagen). Fort Knox, KY: US Army Medical Research Laboratory (republished, 1970).
34. Hascall VC (2000). Hyaluronan, a common thread. Glycoconj J 17:607-616.
35. Hornigold N, Devlin J, Davies AM, Aveyard JS, Habuchi T, Knowles MA (1999). Mutation of the 9q34 gene TSC1 in sporadic bladder cancer. Oncogene 18:2657-2661.
36. Ichikawa D, Handa K, Withers DA, Hakomori S (1997). Histo-blood group A/B versus H status of human carcinoma cells as correlated with haptotactic cell motility: approach with A and B gene transfection. Cancer Res 57:3092-3096.
37. Ichikawa D, Handa K, Hakomori S (1998). Histo-blood group A/B antigen deletion/reduction vs. continuous expression in human tumor cells as correlated with their malignancy. Int J Cancer 76:284-289.
38. Ilver D, Arnqvist A, Ogren J, Frick IM, Kersulyte D, Incecik ET (1998). Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 279:373-377.
39. Iwamoto S, Withers DA, Handa K, Hakomori S (1999). Deletion of A-antigen in a human cancer cell line is associated with reduced promoter activity of CBF/NF-Y binding region, and possibly with enhanced DNA methylation of A transferase promoter. Glycoconj J 16:659-666.
40. Johansson I, Bratt P, Hay DI, Schluckebier S, Stromberg N (2000). Adhesion of Candida albicans, but not Candida krusei, to salivary statherin and mimicking host molecules. Oral Microbiol Immunol 15:112-118.
41. Knudson AG (2001). Two genetic hits (more or less) to cancer. Nat Rev Cancer 1:157-162.
42. Koda Y, Soejima M, Kimura H (1997a). Structure and expression of H-type GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase gene (FUT1). Two transcription start sites and alternative splicing generate several forms of FUT1 mRNA. J Biol Chem 272:7501-7505.
43. Koda Y, Soejima M, Wang B, Kimura H (1997b). Structure and expression of the gene encoding secretor-type galactoside 2-alpha-L-fucosyltransferase (FUT2). Eur J Biochem 246:750-755.
44. Kominato Y, Hata Y, Takizawa H, Tsuchiya T, Tsukada J, Yamamoto F (1999). Expression of human histo-blood group ABO genes is dependent upon DNA methylation of the promoter region. J Biol Chem 274:37240-37250.
45. Kominato Y, Hata Y, Takizawa H, Matsumoto K, Yasui K, Tsukada J, et al. (2002). Alternative promoter identified between a hypermethylated upstream region of repetitive elements and a CpG island in human ABO histo-blood group genes. J Biol Chem 277:37936-37948.
46. Le Pendu J, Marionneau S, Cailleau-Thomas A, Rocher J, Moullac-Vaidye B, Clement M (2001). ABH and Lewis histo-blood group antigens in cancer. APMIS 109:9-31.
47. Mackenzie IC, Dabelsteen E, Zimmermann K (1977). The relationship between expression of epithelial B-like blood group antigen, cell movement and cell proliferation. Acta Pathol Microbiol Scand 85(A):49-56.
48. Mackenzie IC, Dabelsteen E, Rittman G, Junggren L, Toh H (1995). Expression of blood group-related glycoconjugates in the junctional and other oral epithelia of rodents. Anat Rec 241:310-318.
49. Mandel U, Orntoft TF, Holmes EH, Sorensen H, Clausen H, Hakomori S, et al (1991). Lewis blood group antigens in salivary glands and stratified epithelium: lack of regulation of Lewis antigen expression in ductal and buccal mucosal lining epithelia. Vox Sang 61:205-214.
50. Mandel U, Langkilde NC, Orntoft TF, Therkildsen MH, Karkov J, Reibel J, et al. (1992). Expression of histo-blood-group-A/B-gene-defined glycosyltransferases in normal and malignant epithelia: correlation with A/B-carbohydrate expression. Int J Cancer 52:7-12.
51. Marionneau S, Moullac-Vaidye B, Le Pendu J (2002). Expression of histoblood group A antigen increases resistance to apoptosis and facilitates escape from immune control of rat colon carcinoma cells. Glycobiology 12:851-856.
52. Miyake M, Hakomori SI (1991). A specific cell surface glycoconjugate controlling cell motility: evidence by functional monoclonal antibodies that inhibit cell motility and tumor cell metastasis. Biochemistry 30:3328-3334.
53. Moloney DJ, Panin VM, Johnston SH, Chen J, Shao L, Wilson R, et al. (2000). Fringe is a glycosyltransferase that modifies Notch. Nature 406:369-375.
54. Olsson ML, Irshaid NM, Hosseini-Maaf B, Hellberg A, Moulds MK, Sareneva H, et al. (2001). Genomic analysis of clinical samples with serologic ABO blood grouping discrepancies: identification of 15 novel A and B subgroup alleles. Blood 98:1585-1593.
55. Oriol R, Candelier JJ, Mollicone R (2000). Molecular genetics of H. Vox Sang 78(Suppl 2):105-108.
56. Orlow I, Lianes P, Lacombe L, Dalbagni G, Reuter VE, Cordon-Cardo C (1994). Chromosome 9 allelic losses and microsatellite alterations in human bladder tumors. Cancer Res 54:2848-2851.
57. Orlow I, Lacombe L, Pellicer I, Rabbani F, Delgado R, Zhang ZF, et al. (1998). Genotypic and phenotypic characterization of the histoblood group ABO(H) in primary bladder tumors. Int J Cancer 75:819-824.
58. Orntoft TF, Meldgaard P, Pedersen B, Wolf H (1996). The blood group ABO gene transcript is down-regulated in human bladder tumors and growth-stimulated urothelial cell lines. Cancer Res 56:1031-1036.
59. Prokopishyn NL, Puzon-McLaughlin W, Takada Y, Laferte S (1999). Integrin alpha3beta1 expressed by human colon cancer cells is a major carrier of oncodevelopmental carbohydrate epitopes. J Cell Biochem 72:189-209.
60. Ravn V, Dabelsteen E (2000). Tissue distribution of histo-blood group antigens. APMIS 108:1-28.
61. Reibel J, Dabelsteen E, Hakomori S, Young WW, Mackenzie IC (1984). The distribution of blood group antigens in rodent epithelia. Cell Tissue Res 237:111-116.
62. Renkonen J, Heinavaara S, Sankila R, Paavonen T (2000). Endothelial and epithelial expression of sialyl Lewis(x) in squamous carcinoma of the tongue. APMIS 108:705-712.
63. Roseman S (2001). Reflections on glycobiology. J Biol Chem 276:41527-41542.
64. Rouquier S, Lowe JB, Kelly RJ, Fertitta AL, Lennon GG, Giorgi D (1995). Molecular cloning of a human genomic region containing the H blood group alpha(1,2)fucosyltransferase gene and two H locus-related DNA restriction fragments. Isolation of a candidate for the human secretor blood group locus. J Biol Chem 270:4632-4639.
65. Stapleton A, Nudelman E, Clausen H, Hakomori S, Stamm WE (1992). Binding of uropathogenic Escherichia coli R45 to glycolipids extracted from vaginal epithelial cells is dependent on histo-blood group secretor status. J Clin Invest 90:965-972.
66. Szulman AE (1960). The histological distribution of blood group substances A and B in man. J Exp Med 111:785-800.
67. Thomsen O, Friedenreich V, Worsaae E (1930). Uber die Möglichkeit der Existenz sweier neuer Blutgruppen: auch ein Beitrag zur Beleuchtung sogennanter Untergruppen. Acta Pathol Microbiol Scand 7:157-190.
68. Vedtofte P, Dabelsteen E, Hakomori S, Young WW (1984). Regional variations of cell surface carbohydrates in human oral stratified epithelium. Differentiation 25:221-228.
69. Watkins WM (1966). Blood-group substances. Science 152:172-181.
70. Yamamoto F (2000). Molecular genetics of ABO. Vox Sang 78(Suppl 2):91-103.
71. Yamamoto F, Clausen H, White T, Marken J, Hakomori S (1990). Molecular genetic basis of the histo-blood group ABO system. Nature 345:229-233.
72. Yamamoto M, Lin XH, Kominato Y, Hata Y, Noda R, Saitou N, et al. (2001). Murine equivalent of the human histo-blood group ABO gene is a cis-AB gene and encodes a glycosyltransferase with both A and B transferase activity. J Biol Chem 276:13701-13708.